Literature DB >> 2892030

Bismuth/ofloxacin combination for duodenal ulcer.

E Bayerdörffer, T Simon, C Bästlein, R Ottenjann, G Kasper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2892030     DOI： 10.1016/s0140-6736(87)91169-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

2.  One-day high-dose combined therapy of Helicobacter pylori infection.

Authors:  A Dobrucali; M Tuncer; Y T Eralp; S Goksel; M Altin; I Dinc
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

3.  Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.

Authors:  T O'Riordan; E Mathai; E Tobin; D McKenna; C Keane; E Sweeney; C O'Morain
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

Review 4.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

Review 5.  Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors:  A J Wagstaff; P Benfield; J P Monk
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

Review 6.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

7.  One-day therapy for treatment of Helicobacter pylori infection.

Authors:  A Tucci; R Corinaldesi; V Stanghellini; G F Paparo; S Gasperoni; G Biasco; O Varoli; M Ricci-Maccarini; L Barbara
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

8.  Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents.

Authors:  C A McNulty; J C Dent
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

Review 9.  Quinolones and the gastrointestinal tract.

Authors:  B E Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

Review 10.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.